Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference2%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page has undergone significant content changes regarding a clinical study on Parkinson's Disease, with the removal of detailed study descriptions and key inclusion/exclusion criteria, while retaining some core identifiers like the study name and revision number.SummaryDifference34%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check126 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.